Skip to main content

Amendment to pre-order trial for Fluoroquinolone Products

Amendment to pre-order trial for Fluoroquinolone Products

Amendment to pre-order trial for Fluoroquinolone Products

Introduction

The pretrial schedule for the first bellwether trials involving Cipro and Avelox was amended to extend the non-expert fact discovery deadline until January 26, 2018. Fluoroquinolone or peripheral neuropathy lawsuits involving Avelox, Cipro, and Levaquin are a part of the multidistrict litigation 2642 in the U.S. District Court, District of Minnesota. January 19, 2018, is the deadline for completion of case-specific discovery for Avelox-only and Cipro-only cases. As of today, the bellwether trials begin from November 2018 for the Avelox-only cases and from March 4, 2019, for the Cipro-only cases

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!